Related Experiment Video
Updated: Jan 15, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
An insight into the synthesis, structure-activity relationships, and bioactivity of synthetic small molecule ligands
Siti Nor 'Izzah Normizan1, Hongshuang Wang2, Xiaohui Wang3
1Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur, Royal College of Medicine Perak, 30450, Ipoh, Perak, Malaysia.
Abstract:
Toll-like receptor 4 (TLR4), and its co-receptor myeloid differentiation protein 2 (MD-2), form a critical part of the pattern recognition receptor family, playing a central role in innate immune activation, inflammation, and tissue injury responses. Aberrant activation of TLR4 is associated with cytokine storms syndrome and the progression of numerous inflammatory and autoimmune diseases. Conversely, controlled stimulation of TLR4 can enhance adaptive immunity, particularly in the context of vaccine efficacy. These dual roles underscore the therapeutic potential of small molecules that modulate TLR4 signalling. This review provides a comprehensive overview of the synthetic approaches, structure-activity relationships (SAR), and biological activities of small-molecule TLR4 modulators-both agonists and antagonists-that target TLR4, MD-2, or the TLR4/MD-2 complex. The aim is to guide future design and development of selective, potent TLR4-targeted agents with clinical relevance.
More Related Videos
09:04Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 7, 2010
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
Related Concept Videos
Formation of Lipopolysaccharides
Signal Transduction: Overview
Typically, signal transduction involves three...
Ligand Binding and Linkage
Ligand Binding and Linkage
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...